Genetic Factors in Heart Failure and Ways to Reduce Risk

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on genetics & heart health. Browse all Genetics & Heart Health education

Heart failure means the heart can no longer pump blood as efficiently as the body needs, and it affects roughly 6 million American adults. High blood pressure, coronary artery disease, and diabetes are the best-known drivers, but genetics shapes a meaningful share of risk. Some forms run in families through single powerful gene variants; far more reflect many small-effect variants layered on top of lifestyle and other medical conditions.

What role do genes play in heart failure?

Genetic contribution to heart failure falls into two broad buckets. The first is monogenic cardiomyopathy — a single high-impact variant that directly weakens or thickens heart muscle and can be passed to children with roughly 50% probability. The second is polygenic risk, where dozens of common variants each nudge risk slightly by influencing blood pressure, cholesterol, and vascular health. Most people sit in the polygenic category, where genes set a baseline that lifestyle and clinical care can meaningfully modify.

The genes most strongly linked to inherited heart failure

Truncating variants in TTN, the gene for the giant muscle protein titin, are the single most common identifiable genetic cause of dilated cardiomyopathy, found in an estimated 15–25% of familial cases. LMNA variants cause a form of dilated cardiomyopathy often accompanied by conduction-system disease and arrhythmia, which tends to follow a more aggressive course. MYH7 and MYBPC3 are classic hypertrophic-cardiomyopathy genes; the thickened muscle they produce can, over decades, progress toward heart failure. These are the variants cardiologists most often look for when heart failure appears early or clusters in a family.

Blood pressure, natriuretic peptides, and polygenic risk

Beyond the headline cardiomyopathy genes, common variants across many loci shape the pathways that feed heart failure. Variants near lipid genes such as LDLR and PCSK9 influence coronary artery disease, the leading precursor to heart failure. Genes in the natriuretic peptide system — NPPA and NPPB, which encode the hormones ANP and BNP — help regulate blood pressure and fluid balance, and their variants are associated with hypertension. It is no coincidence that BNP is the peptide biomarker clinicians measure to assess heart strain.

Family history: the most accessible genetic clue

You do not need a laboratory to spot a genetic pattern. A first-degree relative with heart failure, unexplained sudden cardiac death before age 50, or a pacemaker at a young age all raise the probability of an inherited component. Sharing an accurate family history with a physician is often the single most useful step, because it determines whether formal cardiac genetic testing and earlier imaging are warranted.

Evidence-based ways to lower cardiovascular risk

Genes are not the whole story, and much of heart failure risk is modifiable. The measures with the strongest evidence are controlling blood pressure, keeping LDL cholesterol in a healthy range, staying physically active, not smoking, limiting alcohol, maintaining a healthy weight, and managing diabetes closely. Regular monitoring with a primary care physician or cardiologist catches early changes when they are most treatable. These steps support heart health broadly — they are risk-reduction tools, not guarantees, and they belong in a plan you build with a qualified provider.

Where genetic insight fits your bigger picture

Understanding your biology adds context to prevention. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, focused on peptide-related biological pathways rather than diagnosing any heart condition. It is educational: it tells you about aspects of your biology, not what to put in your body or whether you will develop heart failure. For questions about inherited cardiomyopathy specifically, dedicated cardiac genetic testing ordered through a physician is the appropriate route.

Frequently Asked Questions About Heart Failure and Genetics

Is heart failure hereditary?

Heart failure can be hereditary. Inherited forms are driven by variants in genes such as TTN, LMNA, MYH7, and MYBPC3, which affect heart muscle directly. More commonly, many small-effect variants combine with high blood pressure, diabetes, and coronary disease to raise risk gradually rather than through a single inherited gene.

Can I prevent heart failure if it runs in my family?

You cannot change your genes, but you can lower modifiable risk substantially. Controlling blood pressure and cholesterol, staying active, not smoking, and managing diabetes all reduce cardiovascular risk. Family history is a signal to start these habits earlier and to discuss cardiac screening with a qualified healthcare provider.

Does a genetic test diagnose heart failure?

No genetic test diagnoses heart failure. Diagnosis is clinical, based on symptoms, physical exam, echocardiogram, and blood markers such as BNP. Genetic testing adds context about inherited risk and can guide screening decisions, but it is one input among many that a physician weighs, not a standalone diagnosis.

Prevention starts with understanding your own biology. Explore the Precision Peptide Genetic Test to understand more about your peptide-related biology — genetics as a guide, not a guarantee.

This article is part of the PlexusDx Education Hub. Browse all Genetics & Heart Health education

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.